P

Inventor

WEILER SVEN

DE13 patents
⚠️ This page may combine multiple inventors who share the name “WEILER SVEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

NOVARTIS AG

8 patents
US10947218B2Mar 16, 2021

Aminopyridine derivatives and their use as selective ALK-2 inhibitors

NOVARTIS AG6 citations81
US10710980B2Jul 14, 2020

Aminopyridine derivatives and their use as selective ALK-2 inhibitors

NOVARTIS AG8 citations81
US8367662B2Feb 5, 2013

Organic compounds

NOVARTIS AG7 citations70
US12466808B2Nov 11, 2025

Aminopyridine derivatives and their use as selective ALK-2 inhibitors

NOVARTIS AG0 citations60
US7696216B2Apr 13, 2010

Aryl-quinazoline/aryl-2-amino-phenyl methanone derivatives

NOVARTIS AG2 citations60
US7977323B2Jul 12, 2011

C2-C5-alkyl-imidazole-bisphosphonates

NOVARTIS AG0 citations49
US11160797B2Nov 2, 2021

Pyridinone derivatives and their use as selective ALK-2 inhibitors

NOVARTIS AG0 citations46
US8030497B2Oct 4, 2011

Benzimidazole derivatives

NOVARTIS AG0 citations40

BEERLI RENE

1 patent
US8476286B2Jul 2, 2013

Quinazoline derivatives which promote the release of parathyroid hormone

BEERLI RENE5 citations65

ALTMANN EVA

1 patent
US8569317B2Oct 29, 2013

Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives

ALTMANN EVA0 citations47

REDONA THERAPEUTICS INC

1 patent
US12583825B2Mar 24, 2026

Benzo[h]quinazolin-4-amine and thieno[3,2-h]quinazolin-4-amine derivatives for the treatment of cancer

REDONA THERAPEUTICS INC0 citations32

LIZOS DIMITRIOS

1 patent
US8143253B2Mar 27, 2012

Organic compounds

LIZOS DIMITRIOS0 citations32

MCQUIRE LESLIE WIGHTON

1 patent
US8841291B2Sep 23, 2014

Selective hydroxamic acid based MMP-12 and MMP-13 inhibitors

MCQUIRE LESLIE WIGHTON0 citations31